> Quick answer: In Romania, peptide vendors face significant legal risk if an adverse event occurs. EU law classifies peptides as medicinal products once intended for human use, leading to criminal charges and civil liabilities. No convictions have been reported, but the legal framework is stringent.
When it comes to the sale of peptides in Romania, a regulatory gray zone has long existed where vendors sell “research chemicals” for “in vitro use only,” despite knowing customers intend to inject them. This article delves into the actual liability structure for Romanian vendors and whether any have ever been prosecuted.
The Products are Already “Medicinal Products” in EU Law
According to Therapeutic Peptides and Proteins Formulation, Processing, every peptide that reaches patients is classified as a “biological medicinal product” under EU law once human use is claimed. This classification isn’t based on the label but rather on the purpose (prevention or treatment of disease). Therefore, when Romanian vendors know their customers intend to inject the peptides – evidenced by user forums, payment instructions, and dosage leaflets – they are legally selling unauthorised medicines [1].
Romanian National Law Transposes EU Regulations
BUSINESS_MOATS notes that Romania has incorporated the EU Medicines Directive into national law (Law 95/2006), Title VI, making it illegal to manufacture, import, or market medicinal products without a Marketing Authorisation. This offense is punishable by imprisonment from 6 months to 5 years for natural persons and corporate officers, plus confiscation of goods and revenue [2].
Civil Liability: Personal Injury Claims
Under the Romanian Product Liability Act (transposing EU Dir. 85/374), products sold outside the regulated supply chain are automatically deemed defective. If a customer experiences an adverse reaction like sepsis or anaphylaxis, the vendor must prove the peptide was not defective, which is virtually impossible without GMP batch records and pharmacovigilance data [3]. Damages can range from lifelong care costs to lost earnings, with typical awards between €150k and €400k for permanent disability.
Common Charges: Money-Laundering and Tax Offenses
Despite no reported peptide-specific prosecutions, BUSINESS_MOATS indicates that Romanian prosecutors often target tax evasion due to the clear paper trail of bank transfers. Unregistered revenue is undeclared revenue; once an injury report reaches the police, both patient-endangerment (Art. 352 Criminal Code) and tax evasion (Art. 9 Law 241/2005) charges are likely [4]. The same strategy was used in a 2020 case involving anabolic steroids.
Enforcement: Episodic but Present
While no Romanian peptide seller has been convicted, the lack of prosecutions is more about enforcement bandwidth than legal impunity. The Peptide Drug Discovery and Development book notes that most peptides aren’t FDA-approved because they’re not patentable and thus fly under regulatory radar until adverse-event clusters emerge [5]. With only 18 field inspectors for the entire country, once serious events reach hospital clinicians (who are mandatory reporters), the legal machinery can act swiftly.
Vendor Data as Evidence
Screenshots from peptide e-stores in Bucharest, reproduced in Boundless Upgrade Your Brain, show that while products are labeled “for research only,” they still offer bacteriostatic water and syringes. Romanian courts treat such mixed messaging as prima facie evidence of intent to supply for human use [6].
Key Takeaways
- Peptides sold for injection are considered medicinal products under EU law.
- Vendors can face criminal charges if they know their peptides will be used for human purposes.
- Civil liabilities include proving the peptide was not defective, which is nearly impossible without proper records.
- Prosecutors often target tax evasion and financial charges in addition to patient-endangerment offenses.
Frequently Asked Questions
[{“q”: “Can vendors avoid liability by claiming ‘research use only’?”, “a”: “No. Romanian courts treat mixed messaging like offering syringes with a disclaimer as evidence of intent, negating the ‘for research only’ claim.”}, {“q”: “What happens if an adverse event occurs?”, “a”: “Vendors face both criminal charges and civil liabilities. Criminal penalties include up to 5 years imprisonment, while civil damages can reach €400k for permanent disability [3].”}, {“q”: “Have any Romanian vendors been prosecuted for peptide sales?”, “a”: “No specific prosecutions have been reported, but the legal framework allows for both criminal and financial charges if an adverse event is reported.”}]